Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin
Article first published online: 19 FEB 2013
© 2013 The Authors. The Journal of Physiology © 2013 The Physiological Society
The Journal of Physiology
Volume 591, Issue 7, pages 1731–1747, April 2013
How to Cite
Zhang, X. and van den Pol, A. N. (2013), Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin. The Journal of Physiology, 591: 1731–1747. doi: 10.1113/jphysiol.2012.248385
- Issue published online: 27 MAR 2013
- Article first published online: 19 FEB 2013
- Accepted manuscript online: 17 JAN 2013 05:31AM EST
- (Resubmitted 13 November 2012; accepted after revision 10 January 2013; first published online 14 January 2013)
- • In conjunction with fast amino acid transmitters, neuropeptides such as dynorphin play key roles in regulating energy homeostasis.
- • Dynorphin immunoreactive axons are abundant in the hypothalamic arcuate nucleus and terminate near or on proopiomelanocortin (POMC) neurons.
- • Dynorphin directly inhibits POMC cells by a mechanism based on activation of GIRK channels, mediated by kappa-2 opioid receptors.
- • Dynorphin indirectly modulates the activity of POMC neurons by depressing afferent glutamate and GABA synaptic neurotransmission.
- • These data suggest that dynorphin-containing neurons could modulate food intake and energy homeostasis by directly attenuating the activity of the anorexigenic POMC cell.
Abstract Dynorphin, an endogenous ligand of kappa (κ) opioid receptors, has multiple roles in the brain, and plays a positive role in energy balance and food intake. However, the mechanism for this is unclear. With immunocytochemistry, we find that axonal dynorphin immunoreactivity in the arcuate nucleus is strong, and that a large number of dynorphin-immunoreactive boutons terminate on or near anorexigenic proopiomelanocortin (POMC) cells. Here we provide evidence from whole-cell patch-clamp recording that dynorphin-A (Dyn-A) directly and dose-dependently inhibits arcuate nucleus POMC neurons. Dyn-A inhibition was eliminated by the κ opioid receptor antagonist nor-BNI, but not by the μ receptor antagonist CTAP. The inhibitory effect was mimicked by the κ2 receptor agonist GR89696, but not by the κ1 receptor agonist U69593. No presynaptic effect of κ2 agonists was found. These results suggest that Dyn-A inhibits POMC neurons through activation of the κ2 opioid receptor. In whole-cell voltage clamp, Dyn-A opened G-protein-coupled inwardly rectifying potassium (GIRK)-like channels on POMC neurons. Dynorphin attenuated glutamate and GABA neurotransmission to POMC neurons. In contrast to the strong inhibition of POMC neurons by Dyn-A, we found a weaker direct inhibitory effect of Dyn-A on arcuate nucleus neuropeptide Y (NPY) neurons mediated by both κ1 and κ2 receptors. Taken together, these results indicate a direct inhibitory effect of Dyn-A on POMC neurons through activation of the κ2 opioid receptor and GIRK channels. A number of orexigenic hypothalamic neurons release dynorphin along with other neuropeptides. The inhibition of anorexigenic POMC neurons may be one mechanism underlying the orexigenic actions of dynorphin.